{"id":"W112559982","doi":"10.1182/blood.v122.21.92.92","title":"ENESTnd Update: Nilotinib (NIL) Vs Imatinib (IM) In Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP) and The Impact Of Early Molecular Response (EMR) and Sokal Risk At Diagnosis On Long-Term Outcomes","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Nilotinib; Discontinuation; Internal medicine; Imatinib mesylate; Imatinib; Myeloid leukemia; Gastroenterology; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002648185,0.000406416,0.001466262,0.0002548426,0.0001608347,0.0008814314,0.000519591,0.0006334459,0.002414902],"category_scores_gemma":[0.001524281,0.0002313026,0.001119163,0.0002717237,0.000234436,0.0006214171,0.0003821028,0.001271432,0.0003295364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005503687,"about_ca_system_score_gemma":0.0005917185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004587559,"about_ca_topic_score_gemma":0.003263712,"domain_scores_codex":[0.9993362,0.000410571,0.00007850388,0.0000510987,0.00008044684,0.00004315267],"domain_scores_gemma":[0.9986128,0.0005208163,0.0004131952,0.00006155467,0.0001271193,0.0002645577],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6772764,0.004923007,0.02354014,0.002910631,0.003875786,0.0001856308,0.0001264983,0.002487115,0.00850571,0.0005295825,0.01365463,0.2619847],"study_design_scores_gemma":[0.5006631,0.2754273,0.1329929,0.001148569,0.01509888,0.001033732,0.0002741122,0.005116522,0.005939661,0.00111038,0.06104152,0.00015334],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9273142,0.05001757,0.001054084,0.003702675,0.0008630885,0.00131963,0.007045045,0.0001106292,0.008573096],"genre_scores_gemma":[0.9580681,0.01954292,0.002301432,0.003192858,0.0009118739,0.001404351,0.008119529,0.00003241972,0.006426554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002648185,"threshold_uncertainty_score":0.01400512,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008635732933922944,"score_gpt":0.2706753204529666,"score_spread":0.2620395875190437,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}